
Warp Sciences is building scientific infrastructure in the U.S. to help the world discover new medicines faster. It brings AI, robotics, and life sciences together in labs built for increasing automation, designed to run and learn from experiments so each cycle can improve the next. Warp has no proprietary drug pipeline. It builds the infrastructure for the research teams discovering new medicines. Its founders, Kevin Weil, DJ Patil, Sol Reisberg and Mano Paluri, bring experience from OpenAI, Terremoto Biosciences, Meta, Devoted Health and the White House.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/22/26 | $215,000,000 | Seed |
01 Advisors Angular Ventures Conviction Gigascale Capital Innovation Endeavors IVP Lightspeed Venture Partners ![]() Lowercarbon Capital Lux Capital Matter Venture Partners Mayfield Menlo Ventures Premji Invest Scribble Ventures SignalFire Standard Capital Uncork Capital | undisclosed |